1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Latin America Active Pharmaceutical Ingredients (API) Market Outlook (2014-2022)

The “Latin America Active Pharmaceutical Ingredients (API) Market” report provides an in-depth analysis of the various market segments and its sub-segments. The Active Pharmaceutical Ingredients (API) market is segmented on the basis of type of API, manufacturers, therapeutic area and geography. On the basis of type of API, the active pharmaceutical ingredients market is segmented into synthetic chemical API and biological API. By type of manufacturers, the market is categorized into captive (or in-house) and contract manufacturing. By therapeutic applications, the market is segmented into oncology, anti-Infectives, cardiovascular and hematopoietic system, gastrointestinal disorder, hormonal-related disorder, metabolic disorder, musculo-skeletal disorder and others. Based on the geography the market is categorized into Argentina, Brazil and rest of Latin America.

The report focuses on current and upcoming market trends such as Drivers, Constraints, Opportunities, and Challenges, technological advancements, Porters Five Forces analysis to assess the intensity of competition in the market. The market values are presented in the form of tables and graphs for better interpretation.

Market Size Estimations
The market assessment is made by the core industry experts using our 360° research approach. The data is derived from the most reliable, authenticated data sources and is validated by the industry experts (Primary Research). Both top down and bottom up analysis are implemented to enhance the accuracy of the market figures. The market projections are calculated for the next 8 years using the actual market numbers of previous year as the base year.

Company Profiling
This section provides the overview of the key players that are leading in the industry, covering their business operations, financials, list of products & services, SWOT analysis, major developments such as mergers & acquisitions, agreements, partnerships, joint ventures, new product launch, expansions etc.

Report Highlights:
- Market share assessments for all the mentioned market segments and sub-segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 8 years for all the given segments
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping, mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Table Of Contents

Latin America Active Pharmaceutical Ingredients (API) Market Outlook (2014-2022)
1 Executive Summary

2 Preface
2.1 Abstract
2.2 Research Scope
2.3 Research Methodology
2.4 Research Sources

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Latin America Active Pharmaceutical Ingredients Market, By Types of API
5.1 Introduction
5.2 Synthetic chemical API
5.3 Biological API

6 Latin America Active Pharmaceutical Ingredients Market, By Type of manufacturing
6.1 Introduction
6.2 Captive (or in-house) manufacturing
6.3 Contract manufacturing

7 Latin America Active Pharmaceutical Ingredients Market, By Therapeutic applications
7.1 Introduction
7.2 Oncology
7.3 Anti-Infectives
7.4 Cardiovascular and hematopoietic system
7.5 Gastrointestinal disorder
7.6 Hormonal-related disorder
7.7 Metabolic disorder
7.8 Musculo-skeletal disorder

8 Latin America Active Pharmaceutical Ingredients Market, By Geography
8.1 Latin America
8.1.1 Argentina
8.1.2 Brazil
8.1.3 Rest of Latin America

9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions and Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling
10.1 Zoetis (U.S.)
10.2 Merck Animal Health (U.S.)
10.3 Merial Inc. (Sanofi) (France)
10.4 Elanco Animal Health (U.S.)
10.5 Boehringer Ingelheim (Germany)
10.6 Bayer Healthcare (Germany)
10.7 Bioniche Animal Health (Argentina)
10.8 Heska Co. (U.S.)
10.9 Ceva Animal Health, Inc.
10.10 Virbac

List of Tables
1 Latin America Chemical Seed treatment Market, By Countries (2012-2022) ($MN)
2 Latin America Active Pharmaceutical Ingredients Market, By Types of API (2012-2022) ($MN)
3 Argentina Active Pharmaceutical Ingredients Market, By Types of API (2012-2022) ($MN)
4 Brazil Active Pharmaceutical Ingredients Market, By Types of API (2012-2022) ($MN)
5 Rest of Latin America Active Pharmaceutical Ingredients Market, By Types of API (2012-2022) ($MN)
6 Latin America Active Pharmaceutical Ingredients Market, By Synthetic chemical API (2012-2022) ($MN)
7 Latin America Active Pharmaceutical Ingredients Market, By Biological API (2012-2022) ($MN)
8 Latin America Active Pharmaceutical Ingredients Market, By Type of manufacturing (2012-2022) ($MN)
9 Argentina Active Pharmaceutical Ingredients Market, By Type of manufacturing (2012-2022) ($MN)
10 Brazil Active Pharmaceutical Ingredients Market, By Type of manufacturing (2012-2022) ($MN)
11 Rest of Latin America Active Pharmaceutical Ingredients Market, By Type of manufacturing (2012-2022) ($MN)
12 Latin America Active Pharmaceutical Ingredients Market, By Captive (or in-house) manufacturing (2012-2022) ($MN)
13 Latin America Active Pharmaceutical Ingredients Market, By Contract manufacturing (2012-2022) ($MN)
14 Latin America Active Pharmaceutical Ingredients Market, By Therapeutic applications (2012-2022) ($MN)
15 Argentina Active Pharmaceutical Ingredients Market, By Therapeutic applications (2012-2022) ($MN)
16 Brazil Active Pharmaceutical Ingredients Market, By Therapeutic applications (2012-2022) ($MN)
17 Rest of Latin America Active Pharmaceutical Ingredients Market, By Therapeutic applications (2012-2022) ($MN)
18 Latin America Active Pharmaceutical Ingredients Market, By Oncology (2012-2022) ($MN)
19 Latin America Active Pharmaceutical Ingredients Market, By Anti-Infectives (2012-2022) ($MN)
20 Latin America Active Pharmaceutical Ingredients Market, By Cardiovascular and hematopoietic system (2012-2022) ($MN)
21 Latin America Active Pharmaceutical Ingredients Market, By Gastrointestinal disorder (2012-2022) ($MN)
22 Latin America Active Pharmaceutical Ingredients Market, By Hormonal-related disorder (2012-2022) ($MN)
23 Latin America Active Pharmaceutical Ingredients Market, By Metabolic disorder (2012-2022) ($MN)
24 Latin America Active Pharmaceutical Ingredients Market, By Musculo-skeletal disorder (2012-2022) ($MN)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.